2015
DOI: 10.1136/archdischild-2014-307985
|View full text |Cite
|
Sign up to set email alerts
|

Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists

Abstract: Non-alcoholic fatty liver disease (NAFLD) is the most common paediatric liver disease with a prevalence of almost 10%; therefore, the majority of affected patients are under the care of general practitioners and non-specialists. The condition is caused by central obesity with insulin resistance with additional factors influencing inflammatory activity (steatohepatitis). Ongoing inflammation leads to fibrosis and end-stage liver disease, though this will usually occur after children have transitioned into adult… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
28
0
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(30 citation statements)
references
References 71 publications
0
28
0
2
Order By: Relevance
“…According to Mann et al (45), non-alcoholic fatty liver disease (NAFLD) affects around 10% of the pediatric population (45,46). The minority of children undergo biopsy but currently there is no other method to accurately assess the stage of disease.…”
Section: Non-alcoholic Fatty Liver Disease (Nafld)mentioning
confidence: 99%
“…According to Mann et al (45), non-alcoholic fatty liver disease (NAFLD) affects around 10% of the pediatric population (45,46). The minority of children undergo biopsy but currently there is no other method to accurately assess the stage of disease.…”
Section: Non-alcoholic Fatty Liver Disease (Nafld)mentioning
confidence: 99%
“…Sin embargo, la ALT no es ni sensible ni específica de NAFLD, ya que los valores pueden fluctuar y hasta ser normales en pacientes con NAFLD, NASH y aun cirrosis. 8,12,17 La biopsia hepática se considera el patrón para el diagnóstico de NAFLD y puede distinguir la esteatosis simple de la NASH, definir el grado de fibrosis y colaborar en el diagnóstico diferencial. No obstante, es un procedimiento invasivo, relativamente costoso y asociado a un número infrecuente pero significativo de complicaciones.…”
Section: Diagnósticounclassified
“…Tiene mayor especificidad que la ultrasonografía, pero no se aconseja su uso rutinario, debido a la exposición a radiación que genera. 12,[15][16][17][18] La resonancia nuclear magnética (RNM) puede proporcionar una medida cuantitativa de la grasa infiltrada, aunque existen escasos estudios vinculados con su utilización en l a p o b l a c i ó n p e d i á t r i c a . P u e d e d e t e c t a r hasta un 3% de esteatosis y está sometida a menor variabilidad, lo que le otorga mayor sensibilidad que la ultrasonografía.…”
Section: Diagnósticounclassified
“…A CT is more specific than an ultrasound, but it is not recommended for routine use because of radiation exposure. 12,[15][16][17][18] A magnetic resonance imaging (MRI) may provide a quantitative measure of infiltrated fat, but few studies have investigated its use in the pediatric population. An MRI may detect up to 3% of steatosis and has a lower variability, making it more sensitive than an ultrasound.…”
Section: Diagnosismentioning
confidence: 99%
“…However, an ALT finding is not sensitive or specific to NAFLD, given that its value may fluctuate and even be normal in patients with NAFLD, NASH, or cirrhosis. 8,12,17 A liver biopsy is the gold standard for NAFLD diagnosis and helps to differentiate simple steatosis from NASH, establish the degree of fibrosis, and make a differential diagnosis. However, it is an invasive, relatively costly procedure associated with an uncommon though significant number of complications.…”
Section: Diagnosismentioning
confidence: 99%